BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16985618)

  • 21. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.
    Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR
    Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Two cases of bladder cancer with hereditary nonpolyposis colorectal cancer].
    Kawaoka T; Miyagawa Y; Tsujihata M; Kamoto A; Nonomura N; Okuyama A
    Hinyokika Kiyo; 2011 Jun; 57(6):319-21. PubMed ID: 21795835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hereditary nonpolyposis colorectal carcinoma (HNPCC): surgical aspects].
    Möslein G
    Praxis (Bern 1994); 2001 Mar; 90(12):483-9. PubMed ID: 11324307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined molecular and clinical approach for decision making for surgery in HNPCC patients: a report on three cases in two families.
    Pistorius SR; Nagel M; Kruger S; Plaschke J; Kruppa C; Wehrmann U; Schackert HK; Saeger HD
    Int J Colorectal Dis; 2001 Nov; 16(6):402-7. PubMed ID: 11760904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.
    Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C
    Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC).
    Müller A; Fishel R
    Cancer Invest; 2002; 20(1):102-9. PubMed ID: 11852992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): criteria for identification and management.
    Kouraklis G; Misiakos EP
    Dig Dis Sci; 2005 Feb; 50(2):336-44. PubMed ID: 15745097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases.
    Peel DJ; Ziogas A; Fox EA; Gildea M; Laham B; Clements E; Kolodner RD; Anton-Culver H
    J Natl Cancer Inst; 2000 Sep; 92(18):1517-22. PubMed ID: 10995807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Etiology, natural history, management and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications.
    Lynch HT; Lemon SJ; Karr B; Franklin B; Lynch JF; Watson P; Tinley S; Lerman C; Carter C
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):987-91. PubMed ID: 9419392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features and mismatch repair gene mutation screening in Chinese patients with hereditary nonpolyposis colorectal carcinoma.
    Liu SR; Zhao B; Wang ZJ; Wan YL; Huang YT
    World J Gastroenterol; 2004 Sep; 10(18):2647-51. PubMed ID: 15309712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations.
    Halbert CH; Lynch H; Lynch J; Main D; Kucharski S; Rustgi AK; Lerman C
    Arch Intern Med; 2004 Sep; 164(17):1881-7. PubMed ID: 15451763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metachronous urothelial cancer in bilateral upper urinary tracts and bladder associated with hereditary nonpolyposis colorectal cancer].
    Yamada Y; Ueda Y; Higuchi Y; Suzuki T; Maruyama T; Kondoh Y; Nojima M; Noda M; Tomita N; Zozumi M; Hirota S; Yamamoto S
    Hinyokika Kiyo; 2011 Oct; 57(10):559-63. PubMed ID: 22089154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
    Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
    Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoscopic and surgical management of hereditary nonpolyposis colorectal cancer.
    Baucom RB; Wise PE
    Clin Colon Rectal Surg; 2012 Jun; 25(2):90-6. PubMed ID: 23730223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for urinary tract cancer with urine cytology in Lynch syndrome and familial colorectal cancer.
    Myrhøj T; Andersen MB; Bernstein I
    Fam Cancer; 2008; 7(4):303-7. PubMed ID: 18389386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.
    Malander S; Rambech E; Kristoffersson U; Halvarsson B; Ridderheim M; Borg A; Nilbert M
    Gynecol Oncol; 2006 May; 101(2):238-43. PubMed ID: 16360201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Identification and management of HNPCC syndrome (hereditary non polyposis colon cancer), hereditary predisposition to colorectal and endometrial adenocarcinomas].
    Olschwang S; Bonaïti C; Feingold J; Frébourg T; Grandjouan S; Lasset C; Laurent-Puig P; Lecuru F; Millat B; Sobol H; Thomas G; Eisinger F
    Bull Cancer; 2004 Apr; 91(4):303-15. PubMed ID: 15242312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis.
    Park JG; Vasen HF; Park KJ; Peltomaki P; Ponz de Leon M; Rodriguez-Bigas MA; Lubinski J; Beck NE; Bisgaard ML; Miyaki M; Wijnen JT; Baba S; Lynch HT
    Dis Colon Rectum; 1999 Jun; 42(6):710-5; discussion 715-6. PubMed ID: 10378593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced Tumoral MLH1-Expression in MLH1-/PMS2-Deficient Colon Cancer Is Indicative of Sporadic Colon Cancer and Not HNPCC.
    Tarancón-Diez M; Büttner R; Friedrichs N
    Pathol Oncol Res; 2020 Jul; 26(3):1435-1439. PubMed ID: 30613919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees.
    Weber TK; Conlon W; Petrelli NJ; Rodriguez-Bigas M; Keitz B; Pazik J; Farrell C; O'Malley L; Oshalim M; Abdo M; Anderson G; Stoler D; Yandell D
    Cancer Res; 1997 Sep; 57(17):3798-803. PubMed ID: 9288790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.